# Ensign Group, Inc: financial statements, quarterly

ENSG · Nasdaq · CIK 1125376 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ensg.md) · [Financials](/companies/ensg/financials.md) · [Filings](/companies/ensg/filings.md) · [Insiders](/companies/ensg/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ensg/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [959 d](/filings/0001125376-26-000007.md) | [1,010](/filings/0001125376-25-000075.md) | [1,031](/filings/0001125376-25-000142.md) | [1,076](/filings/0001125376-25-000170.md) | [1,126 d](/filings/0001125376-26-000007.md) | [1,167](/filings/0001125376-26-000021.md) | [1,221](/filings/0001125376-26-000034.md) | [1,290](/filings/0001125376-26-000046.md) | [1,354 d](/filings/0001125376-26-000007.md) | [1,382](/filings/0001125376-26-000021.md) | [1,432](/filings/0001125376-26-000034.md) | [1,477](/filings/0001125376-26-000046.md) |
| Cost of revenue | $m | [781 d](/filings/0001125376-26-000007.md) | [799](/filings/0001125376-25-000075.md) | [820](/filings/0001125376-25-000142.md) | [860](/filings/0001125376-25-000170.md) | [897 d](/filings/0001125376-26-000007.md) | [928](/filings/0001125376-26-000021.md) | [972](/filings/0001125376-26-000034.md) | [1,045](/filings/0001125376-26-000046.md) | [1,075 d](/filings/0001125376-26-000007.md) | [1,096](/filings/0001125376-26-000021.md) | [1,134](/filings/0001125376-26-000034.md) | [1,167](/filings/0001125376-26-000046.md) |
| Operating income | $m | [22.8 d](/filings/0001125376-26-000007.md) | [82.2](/filings/0001125376-25-000075.md) | [86.0](/filings/0001125376-25-000142.md) | [89.3](/filings/0001125376-25-000170.md) | [101 d](/filings/0001125376-26-000007.md) | [101](/filings/0001125376-26-000021.md) | [104](/filings/0001125376-26-000034.md) | [96.2](/filings/0001125376-26-000046.md) | [124 d](/filings/0001125376-26-000007.md) | [125](/filings/0001125376-26-000021.md) | [123](/filings/0001125376-26-000034.md) | [138](/filings/0001125376-26-000046.md) |
| Interest expense | $m | [2.0 d](/filings/0001125376-24-000018.md) | [2.0](/filings/0001125376-24-000064.md) | [2.0](/filings/0001125376-25-000142.md) | [2.0](/filings/0001125376-25-000170.md) | [2.3 d](/filings/0001125376-26-000007.md) | [2.0](/filings/0001125376-26-000021.md) | [2.0](/filings/0001125376-26-000034.md) | [2.0](/filings/0001125376-26-000046.md) | [2.0 d](/filings/0001125376-26-000007.md) | [1.9](/filings/0001125376-26-000021.md) | [1.9](/filings/0001125376-26-000034.md) | [2.3](/filings/0001125376-26-000046.md) |
| Income tax | $m | [9.5 d](/filings/0001125376-26-000007.md) | [20.6](/filings/0001125376-25-000075.md) | [20.9](/filings/0001125376-25-000142.md) | [20.1](/filings/0001125376-25-000170.md) | [26.0 d](/filings/0001125376-26-000007.md) | [26.2](/filings/0001125376-26-000021.md) | [27.9](/filings/0001125376-26-000034.md) | [22.7](/filings/0001125376-26-000046.md) | [34.6 d](/filings/0001125376-26-000007.md) | [28.8](/filings/0001125376-26-000021.md) | [33.8](/filings/0001125376-26-000034.md) | [35.8](/filings/0001125376-26-000046.md) |
| Net income | $m | [21.7 d](/filings/0001125376-26-000007.md) | [68.8](/filings/0001125376-25-000170.md) | [71.0](/filings/0001125376-25-000170.md) | [78.4](/filings/0001125376-25-000170.md) | [79.7 d](/filings/0001125376-26-000007.md) | [80.3](/filings/0001125376-26-000046.md) | [84.4](/filings/0001125376-26-000046.md) | [83.8](/filings/0001125376-26-000046.md) | [95.5 d](/filings/0001125376-26-000007.md) | [99.7](/filings/0001125376-26-000046.md) | [99.7](/filings/0001125376-26-000046.md) | [104](/filings/0001125376-26-000046.md) |
| Diluted EPS | $ per share | not reported | [1.19](/filings/0001125376-25-000075.md) | [1.22](/filings/0001125376-25-000142.md) | [1.34](/filings/0001125376-25-000170.md) | not reported | [1.37](/filings/0001125376-26-000021.md) | [1.44](/filings/0001125376-26-000034.md) | [1.42](/filings/0001125376-26-000046.md) | not reported | [1.67](/filings/0001125376-26-000021.md) | [1.68](/filings/0001125376-26-000034.md) | [1.76](/filings/0001125376-26-000046.md) |
| Basic EPS | $ per share | not reported | [1.22](/filings/0001125376-25-000075.md) | [1.26](/filings/0001125376-25-000142.md) | [1.38](/filings/0001125376-25-000170.md) | not reported | [1.41](/filings/0001125376-26-000021.md) | [1.48](/filings/0001125376-26-000034.md) | [1.46](/filings/0001125376-26-000046.md) | not reported | [1.73](/filings/0001125376-26-000021.md) | [1.72](/filings/0001125376-26-000034.md) | [1.80](/filings/0001125376-26-000046.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [510](/filings/0001125376-25-000021.md) | [512](/filings/0001125376-24-000064.md) | [477](/filings/0001125376-24-000135.md) | [532](/filings/0001125376-24-000171.md) | [465](/filings/0001125376-26-000007.md) | [283](/filings/0001125376-25-000075.md) | [364](/filings/0001125376-25-000142.md) | [444](/filings/0001125376-25-000170.md) | [504](/filings/0001125376-26-000046.md) | [539](/filings/0001125376-26-000021.md) | [262](/filings/0001125376-26-000034.md) | [338](/filings/0001125376-26-000046.md) |
| Current assets | $m | [1,047](/filings/0001125376-25-000021.md) | [1,088](/filings/0001125376-24-000064.md) | [1,115](/filings/0001125376-24-000135.md) | [1,197](/filings/0001125376-24-000171.md) | [1,158](/filings/0001125376-26-000007.md) | [986](/filings/0001125376-25-000075.md) | [1,067](/filings/0001125376-25-000142.md) | [1,207](/filings/0001125376-25-000170.md) | [1,272](/filings/0001125376-26-000046.md) | [1,320](/filings/0001125376-26-000021.md) | [1,071](/filings/0001125376-26-000034.md) | [1,155](/filings/0001125376-26-000046.md) |
| Total assets | $m | [4,178](/filings/0001125376-25-000021.md) | [4,308](/filings/0001125376-24-000064.md) | [4,437](/filings/0001125376-24-000135.md) | [4,629](/filings/0001125376-24-000171.md) | [4,669](/filings/0001125376-26-000007.md) | [4,760](/filings/0001125376-25-000075.md) | [4,930](/filings/0001125376-25-000142.md) | [5,226](/filings/0001125376-25-000170.md) | [5,463](/filings/0001125376-26-000046.md) | [5,612](/filings/0001125376-26-000021.md) | [5,749](/filings/0001125376-26-000034.md) | [5,998](/filings/0001125376-26-000046.md) |
| Current liabilities | $m | [735](/filings/0001125376-25-000021.md) | [710](/filings/0001125376-24-000064.md) | [731](/filings/0001125376-24-000135.md) | [769](/filings/0001125376-24-000171.md) | [743](/filings/0001125376-26-000007.md) | [705](/filings/0001125376-25-000075.md) | [756](/filings/0001125376-25-000142.md) | [825](/filings/0001125376-25-000170.md) | [894](/filings/0001125376-26-000046.md) | [848](/filings/0001125376-26-000021.md) | [885](/filings/0001125376-26-000034.md) | [963](/filings/0001125376-26-000046.md) |
| Total liabilities | $m | [2,680](/filings/0001125376-25-000021.md) | [2,725](/filings/0001125376-24-000064.md) | [2,774](/filings/0001125376-24-000135.md) | [2,878](/filings/0001125376-24-000171.md) | [2,829](/filings/0001125376-26-000007.md) | [2,830](/filings/0001125376-25-000075.md) | [2,909](/filings/0001125376-25-000142.md) | [3,104](/filings/0001125376-25-000170.md) | [3,228](/filings/0001125376-26-000046.md) | [3,242](/filings/0001125376-26-000021.md) | [3,304](/filings/0001125376-26-000034.md) | [3,435](/filings/0001125376-26-000046.md) |
| Long-term debt | $m | [145](/filings/0001125376-25-000021.md) | [145](/filings/0001125376-24-000064.md) | [144](/filings/0001125376-24-000135.md) | [143](/filings/0001125376-24-000171.md) | [142](/filings/0001125376-26-000007.md) | [141](/filings/0001125376-25-000075.md) | [140](/filings/0001125376-25-000142.md) | [139](/filings/0001125376-25-000170.md) | [138](/filings/0001125376-26-000046.md) | [136](/filings/0001125376-26-000021.md) | [136](/filings/0001125376-26-000034.md) | [195](/filings/0001125376-26-000046.md) |
| Current portion of debt | $m | [4.0](/filings/0001125376-25-000021.md) | [4.0](/filings/0001125376-24-000064.md) | [4.0](/filings/0001125376-24-000135.md) | [4.1](/filings/0001125376-24-000171.md) | [4.1](/filings/0001125376-26-000007.md) | [4.1](/filings/0001125376-25-000075.md) | [4.2](/filings/0001125376-25-000142.md) | [4.2](/filings/0001125376-25-000170.md) | [4.2](/filings/0001125376-26-000046.md) | [4.3](/filings/0001125376-26-000021.md) | [4.2](/filings/0001125376-26-000034.md) | [4.0](/filings/0001125376-26-000046.md) |
| Shareholders' equity | $m | [1,492](/filings/0001125376-25-000021.md) | [1,578](/filings/0001125376-24-000064.md) | [1,657](/filings/0001125376-24-000135.md) | [1,747](/filings/0001125376-24-000171.md) | [1,837](/filings/0001125376-26-000007.md) | [1,927](/filings/0001125376-25-000075.md) | [2,018](/filings/0001125376-25-000142.md) | [2,119](/filings/0001125376-25-000170.md) | [2,232](/filings/0001125376-26-000046.md) | [2,366](/filings/0001125376-26-000021.md) | [2,442](/filings/0001125376-26-000034.md) | [2,559](/filings/0001125376-26-000046.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [85.3 d](/filings/0001125376-26-000007.md) | [35.3](/filings/0001125376-25-000075.md) | [76.9 d](/filings/0001125376-25-000142.md) | [134 d](/filings/0001125376-25-000170.md) | [100 d](/filings/0001125376-26-000007.md) | [72.2](/filings/0001125376-26-000021.md) | [156 d](/filings/0001125376-26-000034.md) | [153 d](/filings/0001125376-26-000046.md) | [183 d](/filings/0001125376-26-000007.md) | [100](/filings/0001125376-26-000021.md) | [172 d](/filings/0001125376-26-000034.md) | [240 d](/filings/0001125376-26-000046.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [3.2 d](/filings/0001125376-26-000007.md) | [3.4](/filings/0001125376-25-000075.md) | [3.4 d](/filings/0001125376-25-000142.md) | [3.4 d](/filings/0001125376-25-000170.md) | [3.4 d](/filings/0001125376-26-000007.md) | [3.6](/filings/0001125376-26-000021.md) | [3.6 d](/filings/0001125376-26-000034.md) | [3.6 d](/filings/0001125376-26-000046.md) | [3.6 d](/filings/0001125376-26-000007.md) | [3.8](/filings/0001125376-26-000021.md) | [3.8 d](/filings/0001125376-26-000034.md) | [3.8 d](/filings/0001125376-26-000046.md) |
| Share repurchases | $m | [0.0 d](/filings/0001125376-26-000007.md) | [0.0](/filings/0001125376-25-000075.md) | [0.0 d](/filings/0001125376-25-000142.md) | [0.0 d](/filings/0001125376-25-000170.md) | [0.0 d](/filings/0001125376-26-000007.md) | [10.8](/filings/0001125376-26-000021.md) | [9.2 d](/filings/0001125376-26-000034.md) | [0.0 d](/filings/0001125376-26-000046.md) | [0.0 d](/filings/0001125376-26-000007.md) | [0.0](/filings/0001125376-26-000021.md) | [40.0 d](/filings/0001125376-26-000034.md) | [7.4 d](/filings/0001125376-26-000046.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [57.1](/filings/0001125376-24-000064.md) | [57.3](/filings/0001125376-24-000135.md) | [57.3](/filings/0001125376-24-000171.md) | [57.9](/filings/0001125376-25-000075.md) | [58.0](/filings/0001125376-25-000142.md) | [58.4](/filings/0001125376-25-000170.md) | [58.5](/filings/0001125376-26-000021.md) | [58.6](/filings/0001125376-26-000034.md) | [59.0](/filings/0001125376-26-000046.md) | [59.6](/filings/0001125376-26-000021.md) | [59.5](/filings/0001125376-26-000034.md) | [59.3](/filings/0001125376-26-000046.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 58,340,666 at 2026-10-22, from the cover of the [10-Q filed 2026-10-27](/filings/0001125376-26-000046.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 27, 2026, 17:27 ET. No prices; not investment advice.